InvestorWire NewsRoom

Article

Ocugen Inc. (NASDAQ: OCGN) Featured in Virtual Coverage of NobleCon17
January 20, 2021

Ocugen Inc. (NASDAQ: OCGN) Featured in Virtual Coverage of NobleCon17

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. The company’s breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug, and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. For more information, visit the company’s website at www.ocugen.com

To watch the presentation, visit https://ibn.fm/NobleCon17Registration

To view IBN’s virtual coverage of Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, visit https://ibn.fm/NobleCon17

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN used social media and syndicated articles to maximize the visibility of NobleCon17.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).